Multimodal Artificial Intelligence for Non-Invasive Colorectal Cancer Screening Based on Holographic Biology

Multimodal Artificial Intelligence for Non-Invasive Colorectal Cancer Screening Based on Holographic Biology.

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07815093

Enrollment

11000

Registered

2026-09-11

Start date

2026-10-01

Completion date

2028-07-01

Last updated

2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

The purpose of this study is to propose a non-invasive screening method by integrating holographic biological theory and artificial intelligence technology. A colorectal cancer risk assessment model will be constructed by analyzing multimodal data including facial features, tongue image characteristics and exhaled gas. The hypothesis of this study is that the model can attain both sensitivity and specificity of 80%.This study will enroll patients aged 18-80 years scheduled to undergo colonoscopy. All participants shall provide informed consent and sign the informed consent form. Patients will be excluded if they have severe cardiac, cerebral, pulmonary or renal dysfunction, or psychiatric disorders precluding colonoscopy, have a history of gastrointestinal surgery, or have taken bismuth agents or other staining medications. Based on estimates from existing literature, the training set will require tongue images, facial images, exhaled gas analysis results and colonoscopic diagnoses from 5000 patients, and the test set will require such data from 6000 patients.

Interventions

OTHERMultimodal non-invasive detection for colorectal cancer

Collection of facial images, tongue images and exhaled gas data from participants. No therapeutic intervention is performed. The collected multimodal data will be used to build an artificial intelligence-based colorectal cancer risk assessment model.

Study design

Observational model

OTHER

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Inclusion criteria

1. Patients aged 18-80 years scheduled to undergo colonoscopy. 2. All patients provide informed consent and sign the informed consent form.

Exclusion criteria

1. Patients with severe cardiac, cerebral, pulmonary or renal dysfunction, or psychiatric disorders that prevent colonoscopy; 2. Patients with a history of gastrointestinal surgery; 3. Patients taking bismuth agents or other staining medications.

Design outcomes

Primary

Measure	Time frame
Presence of colonic polyps and colorectal cancer.	At the time of enrollment and colonoscopy examination

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026